Back to User profile » Dr Ling Peng
Papers published by Dr Ling Peng:
Probiotic Combination CBLEB Alleviates Streptococcus pneumoniae Infection Through Immune Regulation in Immunocompromised Rats
Lv L, Peng L, Shi D, Shao L, Jiang H, Yan R
Journal of Inflammation Research 2022, 15:987-1004
Published Date: 15 February 2022
Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
Sun Y, Chen B, Li J, Peng L, Li S, Yu X, Li L
Cancer Management and Research 2021, 13:7165-7174
Published Date: 14 September 2021
Immunotherapy-Related Cystitis: Case Report and Review of the Literature
Zhu L, Wang Z, Stebbing J, Wang Z, Peng L
OncoTargets and Therapy 2021, 14:4321-4328
Published Date: 31 July 2021
Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLC
Peng L, Xiao K, Cui J, Ye XH, Zhang YC, Mao L, Selvaggi G, Yen J, Stebbing J
OncoTargets and Therapy 2021, 14:3409-3415
Published Date: 25 May 2021
Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients
Peng L, Wang YN, Tang YM, Zeng L, Liu JF, Zeng Z, Liu J, Shi P, Ye XH, Zhao Q
OncoTargets and Therapy 2017, 10:4261-4267
Published Date: 28 August 2017